Extracorporeal Photopheresis With Low-Dose Immunosuppression in High-Risk Heart Transplant Patients-A Pilot Study.
Transplant International. 2022; 35:10320.
Outcome of Extracorporeal Photopheresis as an Add-On Therapy for Antibody-Mediated Rejection in Lung Transplant Recipients.
Transfusion Medicine & Hemotherapy. 2020 Jun; 47(3):205-213.
